OGD2 Pharma Information

OGD2 Pharma SAS is a Remora Biotech company headquartered in Nantes (France), advancing a proprietary OAcGD2-targeted antibody platform. Our vision is to lead the O-acetylated GD2 (OAcGD2) antibody category – as the sole company developing proprietary antibodies against this novel antigen – and to establish a new generation of precision immunotherapies for neuroblastoma and other OAcGD2-expressing cancers. Our mission is to advance our anti-OAcGD2 platform into clinical development through key strategic partnerships, accelerating first-in-class OAcGD2-directed therapies to children with neuroblastoma and expanding into additional high-need oncology indications.

Website	http://ogd2pharma.com
Employees	10 (2 on RocketReach)
Founded	2014
Address	3 Chemin Du Pressoir Chênaie, Nantes, Pays de la Loire 44100, FR
Phone	+33 2 28 29 95 10
Technologies	JavaScript , HTML , PHP +1 more (view full list)
Industry	Biotechnology, Biotechnology Research, Manufacturing General, Drug Discovery, Manufacturing, Science and Engineering
Keywords	Biotechnology, Research And Development, Pharmaceutical, Pharmaceutical Research, Drug Development, Drug Discovery, Clinical Trials, Biotechnology Research, Clinical Stage, Therapeutics, Drug Manufacturing, Biopharma, Healthcare, Regulatory Affairs, Life Sciences, Health, Medical, Innovation
Competitors	Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb +46 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies
NAICS	NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies